February 25, 2013
Gilead Sciences to Present at Two Upcoming Investor Conferences
- 2013 Citi Global Healthcare Conference on February 26th
-
- 2013 RBC Capital Markets’ Healthcare Conference
on February 27th -
-
Webcasts Available Through Gilead Corporate Website -
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 25, 2013--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company
will be webcasting its corporate presentation at two upcoming investor
conferences: the Citi Global Healthcare Conference and the RBC Capital
Markets’ Healthcare Conference, both taking place in New York.
Robin Washington, Gilead’s Senior Vice President and Chief Financial
Officer, will provide an overview of the company at the Citi conference
on Tuesday, February 26 at 11:05 a.m. Eastern Time (ET) and the RBC
conference on Wednesday, February 27 at 10:30 a.m. ET.
To access the live webcasts or replays via the Internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
Pacific.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor
Relations)
